Literature DB >> 10198261

Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: a low molecular weight factor possibly involved.

A Valerio1, D Basso, L Brigato, G Ceolotto, G Baldo, A Tiengo, M Plebani.   

Abstract

A serious insulin resistance characterizes pancreatic cancer-associated diabetes mellitus. Elsewhere, we demonstrated that MIA PaCa2 cultured cells secrete a soluble factor responsible for reduced glucose tolerance induced in SCID mice. The intracellular mechanism of insulin resistance was investigated in isolated and perfused rat hepatocytes incubated with MIA PaCa2 conditioned medium. Lactate production was reduced compared to hepatocytes incubated with control medium while 1,2-DAG was increased and PKC was activated in the hepatocytes incubated with MIA PaCa2 conditioned medium. This behavior was not reproduced treating the hepatocytes with the growth factors EGF, interleukin Ibeta, interleukin-6, and TGF-beta1. In an attempt to make a biochemical identification of the hypothesized tumor associated-diabetogenic factors we observed a low molecular weight protein in the conditioned medium, absent in the nonconditioned one, that may be responsible for the described behaviors. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198261     DOI: 10.1006/bbrc.1999.0521

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer.

Authors:  Katherine Y Fan; Avani S Dholakia; Aaron T Wild; Zheng Su; Amy Hacker-Prietz; Rachit Kumar; Mary Hodgin; Charles C Hsu; Dung T Le; Ana De Jesus-Acosta; Luis A Diaz; Daniel A Laheru; Ralph H Hruban; Elliot K Fishman; Todd D Brown; Timothy M Pawlik; Christopher L Wolfgang; Phuoc T Tran; Joseph M Herman
Journal:  J Natl Compr Canc Netw       Date:  2014-01       Impact factor: 11.908

Review 2.  Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.

Authors:  Phil A Hart; Melena D Bellin; Dana K Andersen; David Bradley; Zobeida Cruz-Monserrate; Christopher E Forsmark; Mark O Goodarzi; Aida Habtezion; Murray Korc; Yogish C Kudva; Stephen J Pandol; Dhiraj Yadav; Suresh T Chari
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-10-12

3.  Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.

Authors:  Wenchao Gao; Yu Zhou; Qingyan Li; Quanbo Zhou; Langping Tan; Yadong Song; Xiaohui Zhao; Min Yu; Shangyou Zheng; Huilin Ye; Bing Zeng; Qing Lin; Jiajia Zhou; Yimin Liu; Huaiqiu Huang; Hui Zhang; Xuchu Hu; Zhihua Li; Xianhua Dai; Rufu Chen
Journal:  Diabetologia       Date:  2015-01-31       Impact factor: 10.122

Review 4.  New insights into pancreatic cancer-induced paraneoplastic diabetes.

Authors:  Raghuwansh P Sah; Sajan Jiv Singh Nagpal; Debabrata Mukhopadhyay; Suresh T Chari
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

Review 5.  Pancreatic Cancer Screening.

Authors:  Koushik K Das; Dayna Early
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

Review 6.  The early diagnosis of pancreatic cancer and diabetes: what's the relationship?

Authors:  Changsong Zhang; Guangshun Yang; Yang Ling; Guihua Chen; Tianbao Zhou
Journal:  J Gastrointest Oncol       Date:  2014-12

Review 7.  Early Detection of Pancreatic Cancer: Opportunities and Challenges.

Authors:  Aatur D Singhi; Eugene J Koay; Suresh T Chari; Anirban Maitra
Journal:  Gastroenterology       Date:  2019-02-02       Impact factor: 22.682

8.  5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue.

Authors:  René Hennig; Xian-Zhong Ding; Wei-Gang Tong; Matthias B Schneider; Jens Standop; Helmut Friess; Markus W Büchler; Parviz M Pour; Thomas E Adrian
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

9.  Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.

Authors:  Gaurav Aggarwal; Vijaya Ramachandran; Naureen Javeed; Thiruvengadam Arumugam; Shamit Dutta; George G Klee; Eric W Klee; Thomas C Smyrk; William Bamlet; Jing Jing Han; Natalia B Rumie Vittar; Mariza de Andrade; Debabrata Mukhopadhyay; Gloria M Petersen; Martin E Fernandez-Zapico; Craig D Logsdon; Suresh T Chari
Journal:  Gastroenterology       Date:  2012-09-06       Impact factor: 22.682

Review 10.  New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer.

Authors:  Rahul Pannala; Ananda Basu; Gloria M Petersen; Suresh T Chari
Journal:  Lancet Oncol       Date:  2009-01       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.